Home
Conditions
Paraproteinemias

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,004 public trials 571 recruiting studies

Refine in advanced search Browse all conditions

Paraproteinemias trial results

Completed

Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer

NCT00006225

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Breast Cancer, +67 more
Locations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Stem Cell Transplantation in Treating Patients With Hematologic Cancer

NCT00004904

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +87 more
Locations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

NCT00004232

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +87 more
Locations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Safety and Tolerability of Rilonacept in Muckle-Wells Syndrome (MWS) or Schnitzler Syndrome (SchS)

NCT01045772

Conditions: Chronic Disease, Chronic Inducible Urticaria, Chronic Urticaria, +21 more
Locations: Charité University Hospital Berlin, State of Berlin, Germany

View Trial Details

Completed

Tocladesine in Treating Patients With Recurrent or Refractory Multiple Myeloma

NCT00004902

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Cellular Therapy With Cord Blood Cells

NCT00427557

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +30 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Efficacy and Safety of Canakinumab in Schnitzler Syndrome

NCT01276522

Conditions: Immune System Diseases, Immunoproliferative Disorders, Monoclonal Gammopathy of Undetermined Significance, +2 more
Locations: Radboud University Nijmegen Medical Centre Nijmegen, Netherlands

View Trial Details

Completed

A Multicentre, Single-arm, Open-label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma

NCT00420849

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: The Mater Private Centre for Haematology & Oncology South Brisbane, Australia

Wilhelminenspital Vienna, Montlearstrasse 37, Austria

St James's Hospital Dublin, Ireland

H. Clínico de Salamanca Salamanca, Spain

View Trial Details

Completed

Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer

NCT00237627

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +99 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Completed

A Study of Peripheral Blood Progenitor Cells Mobilisation (PBPC) With VTP195183 Plus Granulocyte-Colony Stimulating Factor (G-CSF) Compared to Mobilisation With G-CSF Alone

NCT00234169

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Peter MacCallum Cancer centre Melbourne, Victoria, Australia

View Trial Details

Paraproteinemias

Paraproteinemias trial results

Related conditions